These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 10372650)
1. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells. Shimizu E; Kobayashi Y; Oki Y; Kawasaki T; Yoshimi T; Nakamura H Life Sci; 1999; 64(23):2081-8. PubMed ID: 10372650 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors. Souness JE; Hassall GA; Parrott DP Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of phosphodiesterase inhibitors on accumulation of cyclic AMP in isolated ventricular cardiomyocytes. Kelso EJ; McDermott BJ; Silke B Biochem Pharmacol; 1995 Feb; 49(4):441-52. PubMed ID: 7872950 [TBL] [Abstract][Full Text] [Related]
4. Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes. Kelso EJ; McDermott BJ; Silke B Br J Pharmacol; 1993 Dec; 110(4):1387-94. PubMed ID: 8306078 [TBL] [Abstract][Full Text] [Related]
7. Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells. Pan X; Arauz E; Krzanowski JJ; Fitzpatrick DF; Polson JB Biochem Pharmacol; 1994 Aug; 48(4):827-35. PubMed ID: 7521642 [TBL] [Abstract][Full Text] [Related]
8. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis. Torphy TJ; Zhou HL; Burman M; Huang LB Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659 [TBL] [Abstract][Full Text] [Related]
9. Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells. Hall IP; Widdop S; Townsend P; Daykin K Br J Pharmacol; 1992 Oct; 107(2):422-8. PubMed ID: 1384913 [TBL] [Abstract][Full Text] [Related]
10. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages. Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385 [TBL] [Abstract][Full Text] [Related]
11. Isoenzyme-selective cyclic nucleotide phosphodiesterase inhibitors: effects on airways smooth muscle. Raeburn D; Advenier C Int J Biochem Cell Biol; 1995 Jan; 27(1):29-37. PubMed ID: 7757880 [TBL] [Abstract][Full Text] [Related]
12. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine. Katano Y; Endoh M J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732 [TBL] [Abstract][Full Text] [Related]
13. Resensitization of hepatocyte glucagon-stimulated adenylate cyclase can be inhibited when cyclic AMP phosphodiesterase inhibitors are used to elevate intracellular cyclic AMP concentrations to supraphysiological values. Murphy GJ; Houslay MD Biochem J; 1988 Jan; 249(2):543-7. PubMed ID: 2449179 [TBL] [Abstract][Full Text] [Related]
14. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form. Lavan BE; Lakey T; Houslay MD Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of specific phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation. Thomas RE; Armstrong DT; Gilchrist RB Dev Biol; 2002 Apr; 244(2):215-25. PubMed ID: 11944932 [TBL] [Abstract][Full Text] [Related]
16. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Eckly AE; Lugnier C Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194 [TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea-pig hearts. Bethke T; Meyer W; Schmitz W; Scholz H; Stein B; Thomas K; Wenzlaff H Br J Pharmacol; 1992 Sep; 107(1):127-33. PubMed ID: 1384905 [TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism. Zhu WH; Majluf-Cruz A; Omburo GA Life Sci; 1998; 63(4):265-74. PubMed ID: 9698035 [TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterases in the rat renal vasculature. Jackson EK; Mi Z; Carcillo JA; Gillespie DG; Dubey RK J Cardiovasc Pharmacol; 1997 Dec; 30(6):798-801. PubMed ID: 9436820 [TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase. Wright CD; Kuipers PJ; Kobylarz-Singer D; Devall LJ; Klinkefus BA; Weishaar RE Biochem Pharmacol; 1990 Aug; 40(4):699-707. PubMed ID: 1696820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]